Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2016, Article ID 8591656, 11 pages
http://dx.doi.org/10.1155/2016/8591656
Research Article

Yi-Zhi-Fang-Dai Formula Protects against Aβ1–42 Oligomer Induced Cell Damage via Increasing Hsp70 and Grp78 Expression in SH-SY5Y Cells

1Geriatrics Department of Chinese Medicine, Huadong Hospital, Fudan University, Shanghai, China
2Department of Integrated Chinese and Western Medicine, Huashan Hospital, Fudan University, Shanghai, China
3Department of Neurology, Zhongshan Hospital, Fudan University, Shanghai, China
4Shanghai Jiao Tong University School of Pharmacy, Shanghai, China

Received 28 May 2016; Revised 25 August 2016; Accepted 15 September 2016

Academic Editor: Sai W. Seto

Copyright © 2016 Lumei Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. J. L. Murray, C. Atkinson, K. Bhalla et al., “The state of US health, 1990–2010: burden of diseases, injuries, and risk factors,” The Journal of the American Medical Association, vol. 310, no. 6, pp. 591–606, 2013. View at Publisher · View at Google Scholar
  2. K. Y. Chan, W. Wang, J. J. Wu et al., “Epidemiology of Alzheimer's disease and other forms of dementia in China, 1990–2010: a systematic review and analysis,” The Lancet, vol. 381, no. 9882, pp. 2016–2023, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. B. J. Gilbert, “The role of amyloid β in the pathogenesis of Alzheimer's disease,” Journal of Clinical Pathology, vol. 66, no. 5, pp. 362–366, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. D. J. Selkoe, “Amyloid β protein precursor and the pathogenesis of Alzheimer's disease,” Cell, vol. 58, no. 4, pp. 611–612, 1989. View at Publisher · View at Google Scholar · View at Scopus
  5. J.-Z. Wang, Y.-Y. Xia, I. Grundke-Iqbal, and K. Iqbal, “Abnormal hyperphosphorylation of tau: sites, regulation, and molecular mechanism of neurofibrillary degeneration,” Journal of Alzheimer's Disease, vol. 33, supplement 1, pp. S123–S139, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Martin, X. Latypova, C. M. Wilson, A. Magnaudeix, M.-L. Perrin, and F. Terro, “Tau protein phosphatases in Alzheimer's disease: the leading role of PP2A,” Ageing Research Reviews, vol. 12, no. 1, pp. 39–49, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. D. F. Silva, J. E. Selfridge, J. Lu, L. E, S. M. Cardoso, and R. H. Swerdlow, “Mitochondrial abnormalities in Alzheimer's disease: possible targets for therapeutic intervention,” Advances in Pharmacology, vol. 64, pp. 83–126, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Beyreuther and C. L. Masters, “Amyloid precursor protein (APP) and beta A4 amyloid in the etiology of Alzheimer's disease: precursor-product relationships in the derangement of neuronal function,” Brain Pathology, vol. 1, no. 4, pp. 241–251, 1991. View at Google Scholar
  9. D. J. Selkoe, “The molecular pathology of Alzheimer's disease,” Neuron, vol. 6, no. 4, pp. 487–498, 1991. View at Publisher · View at Google Scholar · View at Scopus
  10. D. J. Selkoe and J. Hardy, “The amyloid hypothesis of Alzheimer's disease at 25 years,” EMBO Molecular Medicine, vol. 8, no. 6, pp. 595–608, 2016. View at Publisher · View at Google Scholar
  11. R.-C. Lu, M.-S. Tan, H. Wang, A.-M. Xie, J.-T. Yu, and L. Tan, “Heat shock protein 70 in Alzheimer's disease,” BioMed Research International, vol. 2014, Article ID 435203, 8 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. P. J. Muchowski and J. L. Wacker, “Modulation of neurodegeneration by molecular chaperones,” Nature Reviews Neuroscience, vol. 6, no. 1, pp. 11–22, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. R. I. Morimoto and M. G. Santoro, “Stress-inducible responses and heat shock proteins: new pharmacologic targets for cytoprotection,” Nature Biotechnology, vol. 16, no. 9, pp. 833–838, 1998. View at Publisher · View at Google Scholar · View at Scopus
  14. S. J. Park, J. H. Shin, J. I. Jeong et al., “Down-regulation of mortalin exacerbates Aβ-mediated mitochondrial fragmentation and dysfunction,” The Journal of Biological Chemistry, vol. 289, no. 4, pp. 2195–2204, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Magrané, R. C. Smith, K. Walsh, and H. W. Querfurth, “Heat shock protein 70 participates in the neuroprotective response to intracellularly expressed β-amyloid in neurons,” The Journal of Neuroscience, vol. 24, no. 7, pp. 1700–1706, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. N. V. Bobkova, D. G. Garbuz, I. Nesterova et al., “Therapeutic effect of exogenous Hsp70 in mouse models of Alzheimer's disease,” Journal of Alzheimer's Disease, vol. 38, no. 2, pp. 425–435, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. M. M. Yurinskaya, V. A. Mitkevich, S. A. Kozin, M. B. Evgen'ev, A. A. Makarov, and M. G. Vinokurov, “HSP70 protects human neuroblastoma cells from apoptosis and oxidative stress induced by amyloid peptide isoAsp7-Aβ(1–42),” Cell Death and Disease, vol. 6, no. 11, Article ID e1977, 2015. View at Publisher · View at Google Scholar
  18. R. J. S. Viana, A. F. Nunes, and C. M. P. Rodrigues, “Endoplasmic reticulum enrollment in Alzheimer's disease,” Molecular Neurobiology, vol. 46, no. 2, pp. 522–534, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. K. M. Doyle, D. Kennedy, A. M. Gorman, S. Gupta, S. J. M. Healy, and A. Samali, “Unfolded proteins and endoplasmic reticulum stress in neurodegenerative disorders,” Journal of Cellular and Molecular Medicine, vol. 15, no. 10, pp. 2025–2039, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. R. O. Costa, E. Ferreiro, S. M. Cardoso, C. R. Oliveira, and C. M. F. Pereira, “ER stress-mediated apoptotic pathway induced by Aβ peptide requires the presence of functional mitochondria,” Journal of Alzheimer's Disease, vol. 20, no. 2, pp. 625–636, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Song, H. Lee, T.-I. Kam et al., “E2-25K/Hip-2 regulates caspase-12 in ER stress-mediated Aβ neurotoxicity,” The Journal of Cell Biology, vol. 182, no. 4, pp. 675–684, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Liu, C. Zhang, B. Kalionis et al., “EGb761 protects against Aβ1-42 oligomer-induced cell damage via endoplasmic reticulum stress activation andHsp70 protein expression increase in SH-SY5Y cells,” Experimental Gerontology, vol. 75, pp. 56–63, 2016. View at Publisher · View at Google Scholar · View at Scopus
  23. W. B. Wan, L. Cao, L. M. Liu et al., “EGb761 provides a protective effect against Aβ142 oligomer-induced cell damage and blood-brain barrier disruption in an in vitro bEnd.3 endothelial model,” PLoS ONE, vol. 9, no. 11, Article ID e113126, 2014. View at Publisher · View at Google Scholar
  24. N. Li, L. Zhou, W. Li, Y. Liu, J. Wang, and P. He, “Protective effects of ginsenosides Rg1 and Rb1 on an Alzheimer's disease mouse model: a metabolomics study,” Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 985, pp. 54–61, 2015. View at Publisher · View at Google Scholar · View at Scopus
  25. C.-R. Wu, H.-C. Lin, and M.-H. Su, “Reversal by aqueous extracts of Cistanche tubulosa from behavioral deficits in Alzheimer's disease-like rat model: relevance for amyloid deposition and central neurotransmitter function,” BMC Complementary and Alternative Medicine, vol. 14, article 202, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. J.-W. Shin, Y.-J. Cheong, Y.-M. Koo et al., “α-Asarone ameliorates memory deficit in lipopolysaccharide-treated mice via suppression of pro-inflammatory cytokines and microglial activation,” Biomolecules and Therapeutics, vol. 22, no. 1, pp. 17–26, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Vázquez De La Torre, F. Junyent, J. Folch et al., “PI3 k/akt inhibition induces apoptosis through p38 activation in neurons,” Pharmacological Research, vol. 70, no. 1, pp. 116–125, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Reitz, “Alzheimer's disease and the amyloid cascade hypothesis: a critical review,” International Journal of Alzheimer's Disease, vol. 2012, Article ID 369808, 11 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. D. E. Hurtado, L. Molina-Porcel, M. Iba et al., “Aβ accelerates the spatiotemporal progression of tau pathology and augments tau amyloidosis in an Alzheimer mouse model,” The American Journal of Pathology, vol. 177, no. 4, pp. 1977–1988, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Song, K. A. Park, W. T. Lee, and J. E. Lee, “Apoptosis signal regulating kinase 1 (ASK1): potential as a therapeutic target for Alzheimer's disease,” International Journal of Molecular Sciences, vol. 15, no. 2, pp. 2119–2129, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Urano, S. Ochiai, and N. Noguchi, “Suppression of amyloid-β production by 24S-hydroxycholesterol via inhibition of intracellular amyloid precursor protein trafficking,” The FASEB Journal, vol. 27, no. 10, pp. 4305–4315, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. N. Soejima, Y. Ohyagi, N. Nakamura et al., “Intracellular accumulation of toxic turn amyloid-β is associated with endoplasmic reticulum stress in Alzheimer's disease,” Current Alzheimer Research, vol. 10, no. 1, pp. 11–20, 2013. View at Google Scholar · View at Scopus
  33. Y. Kimata and K. Kohno, “Endoplasmic reticulum stress-sensing mechanisms in yeast and mammalian cells,” Current Opinion in Cell Biology, vol. 23, no. 2, pp. 135–142, 2011. View at Publisher · View at Google Scholar · View at Scopus